Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9316589, 6 pages
https://doi.org/10.1155/2017/9316589
Research Article

Clinical Features and Outcome in Adult Cases of Tuberculous Meningitis in Tertiary Care Hospital in Antananarivo, Madagascar

1Service des Maladies Infectieuses, Hôpital Universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar
2Service des Maladies Infectieuses, CHU Tambohobe, Fianarantsoa, Madagascar
3Université de Fianarantsoa, Fianarantsoa, Madagascar
4Programme National de Lutte contre la Tuberculose (PNLT), Ministère de la Santé Publique, Antananarivo, Madagascar

Correspondence should be addressed to Mihaja Raberahona; moc.liamg@anoharebar

Received 10 December 2016; Accepted 5 March 2017; Published 15 March 2017

Academic Editor: Valeria Rolla

Copyright © 2017 Mihaja Raberahona et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Tuberculosis Report 2013, WHO, Geneva, Switzerland, 2013.
  2. M. Phypers, T. Harris, and C. Power, “CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features,” International Journal of Tuberculosis and Lung Disease, vol. 10, no. 1, pp. 99–103, 2006. View at Google Scholar · View at Scopus
  3. CDC, Reported Tuberculosis in the United States, 2013, CDC, Atlanta, Ga, USA, 2014.
  4. Y. W. Woldeamanuel and B. Girma, “A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa,” Journal of Neurology, vol. 261, no. 5, pp. 851–865, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kalita, U. K. Misra, and P. Ranjan, “Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis,” European Journal of Neurology, vol. 14, no. 1, pp. 33–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Ho, B. J. Marais, G. L. Gilbert, and A. P. Ralph, “Diagnosing tuberculous meningitis—have we made any progress?” Tropical Medicine and International Health, vol. 18, no. 6, pp. 783–793, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Marais, G. Thwaites, J. F. Schoeman et al., “Tuberculous meningitis: a uniform case definition for use in clinical research,” The Lancet Infectious Diseases, vol. 10, no. 11, pp. 803–812, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. B. Rock, M. Olin, C. A. Baker, T. W. Molitor, and P. K. Peterson, “Central nervous system tuberculosis: pathogenesis and clinical aspects,” Clinical Microbiology Reviews, vol. 21, no. 2, pp. 243–261, 2008. View at Publisher · View at Google Scholar
  9. G. E. Thwaites, T. T. H. Chau, K. Stepniewska et al., “Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features,” Lancet, vol. 360, no. 9342, pp. 1287–1292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. E. G. Miftode, O. S. Dorneanu, D. A. Leca et al., “Tuberculous meningitis in children and adults: a 10-year retrospective comparative analysis,” PLoS ONE, vol. 10, no. 7, Article ID e0133477, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. N. Sutlas, A. Unal, H. Forta, S. Senol, and D. Kirbas, “Tuberculous meningitis in adults: review of 61 cases,” Infection, vol. 31, no. 6, pp. 387–391, 2003. View at Publisher · View at Google Scholar
  12. S. Hosoglu, M. F. Geyik, I. Balik, B. Aygen, S. Erol, and S. G. Aygencel, “Tuberculous meningitis in adults in Turkey: epidemiology, diagnosis, clinic and laboratory,” European Journal of Epidemiology, vol. 18, no. 4, pp. 337–343, 2003. View at Google Scholar
  13. A.-S. H. Christensen, Å. B. Andersen, V. Ø. Thomsen, P. H. Andersen, and I. S. Johansen, “Tuberculous meningitis in Denmark: a review of 50 cases,” BMC Infectious Diseases, vol. 11, article 47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. N. E. Anderson, J. Somaratne, D. F. Mason, D. Holland, and M. G. Thomas, “A review of tuberculous meningitis at Auckland City Hospital, New Zealand,” Journal of Clinical Neuroscience, vol. 17, no. 8, pp. 1018–1022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Marais, D. J. Pepper, C. Schutz, R. J. Wilkinson, and G. Meintjes, “Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting,” PLoS ONE, vol. 6, no. 5, Article ID e20077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. WHO, World Health Statistics 2014, WHO, Geneva, Switzerland, 2014.
  17. L. Fenner, S. Gagneux, P. Helbling et al., “Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection,” Journal of Clinical Microbiology, vol. 50, no. 2, pp. 388–395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Svensson, J. Millet, A. Lindqvist, M. Olsson, M. Ridell, and N. Rastogi, “Impact of immigration on tuberculosis epidemiology in a low-incidence country,” Clinical Microbiology and Infection, vol. 17, no. 6, pp. 881–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Roca, N. Tornador, and E. Tornador, “Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study,” Epidemiology and Infection, vol. 136, no. 11, pp. 1455–1462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Bidstrup, P. H. Andersen, P. Skinhøj, and Å. B. Andersen, “Tuberculous meningitis in a country with a low incidence of tuberculosis: still a serious disease and a diagnostic challenge,” Scandinavian Journal of Infectious Diseases, vol. 34, no. 11, pp. 811–814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. B. B. Trunz, P. Fine, and C. Dye, “Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness,” Lancet, vol. 367, no. 9517, pp. 1173–1180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Mangtani, I. Abubakar, C. Ariti et al., “Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials,” Clinical Infectious Diseases, vol. 58, no. 4, pp. 470–480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. N. E. Aronson, M. Santosham, G. W. Comstock et al., “Long-term efficacy of BCG vaccine in american indians and alaska natives: a 60-year follow-up study,” JAMA, vol. 291, no. 17, pp. 2086–2091, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Nguipdop-Djomo, E. Heldal, L. C. Rodrigues, I. Abubakar, and P. Mangtani, “Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study,” The Lancet Infectious Diseases, vol. 16, no. 2, pp. 219–226, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. F. G. Youssef, S. A. Afifi, A. M. Azab et al., “Differentiation of tuberculous meningitis from acute bacterial meningitis using simple clinical and laboratory parameters,” Diagnostic Microbiology and Infectious Disease, vol. 55, no. 4, pp. 275–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sunbul, A. Atilla, S. Esen, C. Eroglu, and H. Leblebicioglu, “Thwaites' diagnostic scoring and the prediction of tuberculous meningitis,” Medical Principles and Practice, vol. 14, no. 3, pp. 151–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. E. Török, H. D. T. Nghia, T. T. H. Chau et al., “Validation of a diagnostic algorithm for adult tuberculous meningitis,” American Journal of Tropical Medicine and Hygiene, vol. 77, no. 3, pp. 555–559, 2007. View at Google Scholar · View at Scopus
  28. A. M. Checkley, Y. Njalale, M. Scarborough, and E. E. Zjilstra, “Sensitivity and specificity of an index for the diagnosis of TB meningitis in patients in an urban teaching hospital in Malawi,” Tropical Medicine and International Health, vol. 13, no. 8, pp. 1042–1046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. WHO, Treatment of Tuberculosis: Guidelines, WHO, Geneva, Switzerland, 4th edition, 2010.
  30. G. Thwaites, M. Fisher, C. Hemingway, G. Scott, T. Solomon, and J. Innes, “British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children,” Journal of Infection, vol. 59, no. 3, pp. 167–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. American Thoracic Society, CDC, and Infectious Diseases Society of America, “Treatment of tuberculosis,” MMWR Recommendations and Reports, vol. 52, no. RR-11, pp. 1–77, 2003. View at Google Scholar
  32. S. Jullien, H. Ryan, M. Modi, and R. Bhatia, “Six months therapy for tuberculous meningitis,” The Cochrane Database of Systematic Reviews, no. 9, Article ID CD012091, 2016. View at Publisher · View at Google Scholar
  33. G. E. Thwaites, N. D. Bang, N. H. Dung et al., “The influence of HIV infection on clinical presentation, response to treatment and outcome in adults with tuberculous meningitis,” Journal of Infectious Diseases, vol. 192, no. 12, pp. 2134–2141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. K. Yasar, F. Pehlivanoglu, and G. Sengoz, “Predictors of mortality in tuberculous meningitis: a multivariate analysis of 160 cases,” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 10, pp. 1330–1335, 2010. View at Google Scholar · View at Scopus
  35. E. L. George, T. Iype, A. Cherian et al., “Predictors of mortality in patients with meningeal tuberculosis,” Neurology India, vol. 60, no. 1, pp. 18–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. P. C. Hsu, C. C. Yang, J. J. Ye, P. Y. Huang, P. C. Chiang, and M. H. Lee, “Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in northern Taiwan,” Journal of Microbiology, Immunology and Infection, vol. 43, no. 2, pp. 111–118, 2010. View at Publisher · View at Google Scholar
  37. J. E. T. Shaw, J. G. Pasipanodya, and T. Gumbo, “Meningeal tuberculosis: high long-term mortality despite standard therapy,” Medicine, vol. 89, no. 3, pp. 189–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Hosoglu, M. F. Geyik, I. Balik et al., “Predictors of outcome in patients with tuberculous meningitis,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 1, pp. 64–70, 2002. View at Google Scholar · View at Scopus
  39. J.-J. Sheu, R.-Y. Yuan, and C.-C. Yang, “Predictors for outcome and treatment delay in patients with tuberculous meningitis,” The American Journal of the Medical Sciences, vol. 338, no. 2, pp. 134–139, 2009. View at Publisher · View at Google Scholar